UCLH cancer academy questionnaire

Dear BOPA members

 

UCLH cancer academy has been funded to develop multidisciplinary education on check point inhibitors and immune related adverse events.  We are very keen that the materials we produced are helpful to the whole BOPA membership.  To understand where the gaps are we have developed a questionnaire.  It will take less than 10 minutes to complete and will be really helpful for us to understand where the gaps are at different hospitals.  Please could this be completed asap.  If you have any questions or would like to keep in touch with our work, then please email Elly on [email protected].

https://forms.office.com/e/rAAj4DzjNK

 

Thank in advance!

 

Pinkie Chambers and Elly Ball

UCLH NHS Foundation Trust

 

Latest News

By BOPA on 22nd January 2026

Open Letter to UK Pharmacists, Pharmacy Technicians and Pharmacy Trainees and Students

Open Letter to UK Pharmacists, Pharmacy Technicians and Pharmacy Trainees and Students   Through an open letter published on its website, the UK Pharmacy Professional Leadership Advisory Board is inviting…

Read article
By BOPA Executive Committee on 20th January 2026

Join NCODA in Dublin, Ireland from 11-12 March for the 2026 NCODA Global Oncology & Haematology Congress 

Join NCODA in Dublin, Ireland from 11-12 March for the 2026 NCODA Global Oncology & Haematology Congress — a new international meeting designed to unite leaders in oncology, hematology, diagnostics, and technology for two days of…

Read article
By BOPA Executive Committee on 20th January 2026

The HMP Safety Campaign page is now live!

The HMP Safety Campaign page is now live on the SHBN website: https://shbn.org.uk/hmp-safety/ The campaign has been established to address the ongoing risks faced by healthcare professionals who prepare, administer,…

Read article
By BOPA Research committee on 15th January 2026

Allied health and lifestyle support provision research survey

Dear members, Sheffield Hallam University’s Advanced Wellbeing Research Centre (AWRC) are working on behalf of Pfizer to identify the type of information, support and services offered to people living with metastatic…

Read article